EKF Diagnostics Holdings PLC
LSE:EKF
EKF Diagnostics Holdings PLC
LSE:EKF
Price:
32.45 GBX
-0.76%
Updated:
Jun 3, 2024
EKF Diagnostics Holdings PLC
Accounts Receivables
|
EKF Diagnostics Holdings PLC
Accounts Receivables Peer Comparison
Comparables:
SN
LIVN
LMDX
AGL
CREO
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Accounts Receivables
£6.8m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Accounts Receivables
$209.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
15%
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Accounts Receivables
$26.7m
|
CAGR 3-Years
68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Angle PLC
LSE:AGL
|
Accounts Receivables
£1.4m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Accounts Receivables
£8.6m
|
CAGR 3-Years
23%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
See Also
What is EKF Diagnostics Holdings PLC's Accounts Receivables?
Accounts Receivables
6.8m
GBP
6.8m
GBP
Based on the financial report for Dec 31, 2023, EKF Diagnostics Holdings PLC's Accounts Receivables amounts to 6.8m GBP.
What is EKF Diagnostics Holdings PLC's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-1%
-1%
Over the last year, the Accounts Receivables growth was -37%. The average annual Accounts Receivables growth rates for EKF Diagnostics Holdings PLC have been -20% over the past three years , -2% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
